Sheng Le, Deputy Secretary - General of the Suzhou Municipal Government, and his entourage visited Huiliao Bio for investigation.

On the morning of May 9, 2024, Deputy Secretary-General Sheng Le from the Suzhou Municipal Government Office visited HealBio for a research investigation. Accompanying the visit were relevant officials from the Municipal Agriculture and Rural Affairs Bureau and the Economic Development Committee of the Suzhou Industrial Park.

Accompanied by Dr. Tianyi Zhong, CEO of the company, the Suzhou municipal government delegation toured HealBio's exhibition hall, gaining insights into the company's development history, research and development achievements, product patents, and awards. They engaged in in-depth discussions regarding the company's upstream and downstream supply chains, new veterinary drug registration, R&D investment, and future strategic plans.

In the realm of animal health in Suzhou, Huiliao Biology exemplifies a high-tech, research-oriented enterprise. Vice Secretary-General Sheng lauded Huiliao Biology's contributions to the development of new quality productive forces in veterinary biological products, and fully affirmed the achievements of the park after undertaking the authorization of veterinary drug production licenses and other powers. Huiliao Biology will continue to leverage the advanced advantages of its technology platform to contribute to the development of veterinary medicine and animal husbandry in China.

#About Suzhou Huiliao #

Suzhou Huiliao Biotechnology is a high-tech enterprise engaged in the comprehensive provision of nucleic acid drug industrialization. The company's business spans the research and production of mRNA drugs, clinical trial design, data analysis, and other areas, with a focus on the development of mRNA technology-based infectious disease vaccines, cancer vaccines, cell therapies, protein replacements, and more.